Articles

2016

Re-examining the relationship between active cytomegalovirus (CMV) infection and acute graft-versus-host disease in allogeneic stem cell transplant recipients in the era of real-time PCR CMV assays

Giménez E, Solano C, Piñana JL, Amat P, Vinuesa V, Navarro D.

2016

Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia.

Vidriales MB, Pérez-López E, Pegenaute C, Castellanos M, Pérez JJ, Chandía M, Díaz-Mediavilla J, Rayón C, de Las Heras N, Fernández-Abellán P, Cabezudo M, de Coca AG, Alonso JM, Olivier C, Hernández-Rivas JM, Montesinos P, Fernández R, García-Suárez J, García M, Sayas MJ, Paiva B, González M, Orfao A, San Miguel JF, PETHEMA Programa para el Estudio de la Terapéutica en Hemopatías Malignas Cooperative Study Group.

2016

Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia.

Roboz GJ, Montesinos P, Selleslag D, Wei A, Jang JH, Falantes J, Voso MT, Sayar H, Porkka K, Marlton P, Almeida A, Mohan S, Ravandi F, Garcia-Manero G, Skikne B, Kantarjian H.

2016

Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group.

Ribera JM, García O, Oriol A, Gil C, Montesinos P, Bernal T, González-Campos J, Lavilla E, Ribera J, Brunet S, Martínez MP, Tormo M, Genescà E, Barba P, Sarrà J, Monteserín MC, Soria B, Colorado M, Cladera A, García-Guiñón A, Calbacho M, Serrano A, Ortín X, Pedreño M, Amigo ML, Escoda L, Feliu E, PETHEMA Group, Spanish Society of Hematology.

2016

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations.

Blanco G, Puiggros A, Baliakas P, Athanasiadou A, García-Malo M, Collado R, Xochelli A, Rodríguez-Rivera M, Ortega M, Calasanz MJ, Luño E, Vargas M, Grau J, Martínez-Laperche C, Valiente A, Cervera J, Anagnostopoulos A, Gimeno E, Abella E, Stalika E, Hernández-Rivas JM, Ortuño FJ, Robles D, Ferrer A, Ivars D, González M, Bosch F, Abrisqueta P, Stamatopoulos K, Espinet B.

2016

A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG).

Sammassimo S, Pruneri G, Andreola G, Montoro J, Steffanoni S, Nowakowski GS, Gandini S, Negri M, Habermann TM, Raderer M, Li ZM, Zinzani PL, Adam P, Zucca E, Martinelli G.

2016

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

Palumbo A, Chanan-Khan A, Weisel K, Nooka AK, Masszi T, Beksac M, Spicka I, Hungria V, Munder M, Mateos MV, Mark TM, Qi M, Schecter J, Amin H, Qin X, Deraedt W, Ahmadi T, Spencer A, Sonneveld P; CASTOR Investigators.

2016

IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients.

Corrales I, Solano C, Amat P, Giménez E, de la Cámara R, Nieto J, López J, García-Noblejas A, Piñana JL, Navarro D.

2016

doi: 10.1038/tpj.2015.79Epub 2015 Oct 27

Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis

Megías-Vericat JE, Rojas L, Herrero MJ, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MA, Aliño SF

2016

Review of Cutaneous Graft-vs-Host Disease.

Ballester-Sánchez R; Navarro-Mira M; Sanz-Caballer J; Botella-Estrada R.

2016

doi: 10.1002/ajh.24227

Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases.

Palomo L; Xicoy B; Garcia O; Mallo M; Ademà V; Cabezón M; Arnan M; Pomares H; José Larrayoz M; José Calasanz M; Maciejewski JP; Huang D; Shih LY; Ogawa S; Cervera J; Such E; Coll R; Grau J; Solé F; Zamora L.

2016

Immunophenotypic analysis and quantification of B-1 and B-2 B cells during human fetal hematopoietic development.

Bueno C; van Roon EH; Muñoz-López A; Sanjuan-Pla A; Juan M; Navarro A; Stam RW; Menendez P.

2016

Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice.

González-López TJ; Alvarez-Román MT; Pascual C; Sánchez-González B; Fernández-Fuentes F; Jarque I; Pérez-Rus G; Pérez-Crespo S; Bernat S; Hernández-Rivas JA; Andrade MM; Cortés M; Gómez-Nuñez M; Olivera P; Martínez-Robles V; Fernández-Rodríguez A; Fuertes-Palacio MA; Fernández-Miñano C; de Cabo E; Fisac R; Aguilar C; Bárez A; Peñarrubia MJ; García-Frade LJ; González-Porras JR.

2016

El nuevo reto en oncología: la secuenciación NGS y su aplicación a la medicina de precisión.

Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V.

2016

doi: DOI: 10.1007/s10689-015-9864-2

Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer.

Murria Estal, Rosa; Palanca Suela, Sarai; de Juan Jimenez, Inmaculada; Alenda Gonzalez, Cristina; Egoavil Rojas, Cecilia; Garcia-Casado, Zaida; Lopez Guerrero, Jose Antonio; Juan Fita, Maria Jose; Sanchez Heras, Ana Beatriz; Segura Huerta, Angel; Santaballa Bertran, Ana; Chirivella Gonzalez, Isabel; Llop Garcia, Marta; Perez Simo, Gema; Barragan Gonzalez, Eva; Bolufer Gilabert, Pascual.

2016

Analysis of the Possible Persistent Genotoxic Damage in Workers Linked to the Ardystil Syndrome.

Montoro A, Sebastià N, Hervás D, Esteban V, Bonafont J, Barquinero JF, Almonacid M, Cervera J, Such E, Verdú G, Soriano JM, Villaescusa JI.

2016

doi: 10.3109/10428194.2015.1040013

Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy

Kelleher N, Gallardo D, González-Campos J, Hernández-Rivas JM, Montesinos P, Sarrá J, Gil C, Barba P, Guàrdia R, Brunet S, Bernal T, Martínez MP, Abella E, Bermúdez A, Sánchez-Delgado M, Antònia C, Gayoso J, Calbacho M, Ribera JM; Pethema Group, Spanish Society of Hematology

2015

doi: 10.1007/s10689-015-9814-z

BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.

de Juan I, Palanca S, Domenech A, Feliubadaló L, Segura Á, Osorio A, Chirivella I, de la Hoya M, Sánchez AB, Infante M, Tena I, Díez O, Garcia-Casado Z, Vega A, Teulé À, Barroso A, Pérez P, Durán M, Carrasco E, Juan-Fita MJ, Murria R, Llop M, Barragan E, Izquierdo Á, Benítez J, Caldés T, Salas D, Bolufer P.

2015

doi: 10.1016/j.rx.2015.07.003

Hematologic neoplasms: interpreting lung findings in chest computed tomography.

Calvillo Batllés P, Carreres Polo J, Sanz Caballer J, Salavert Lletí M, Compte Torrero L.

2015

doi: 10.1182/blood-2015-09-667378

Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia

Sanjuan-Pla A, Bueno C, Prieto C, Acha P, Stam RW, Marschalek R, Menéndez P

2015

doi: 10.1038/bmt.2015.181Epub 2015 Aug 17

Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.

Montesinos P, Rodríguez-Veiga R, Boluda B, Martínez-Cuadrón D, Cano I, Lancharro A, Sanz J, Arilla MJ, López-Chuliá F, Navarro I, Lorenzo I, Salavert M, Pemán J, Calvillo P, Martínez J, Carpio N, Jarque I, Sanz GF, Sanz MA

2015

doi: 10.1111/bjh.13607Epub 2015 Jul 24

Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide

Sanford D, Lo-Coco F, Sanz MA, Di Bona E, Coutre S, Altman JK, Wetzler M, Allen SL, Ravandi F, Kantarjian H, Cortes JE

2015

doi: 10.1002/cncr.29579

Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.

Ribera J, Morgades M, Zamora L, Montesinos P, Gómez-Seguí I, Pratcorona M, Sarrà J, Guàrdia R, Nomdedeu J, Tormo M, Martínez-Lopez J, Hernández-Rivas JM, González-Campos J, Barba P, Escoda L, Genescà E, Solé F, Millá F, Feliu E, Ribera JM; Spanish PETHEMA Group and the Spanish Society of Hematology

2015

doi: 10.1093/annonc/mdv317

FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk

Spina M, Nagy Z, Ribera JM, Federico M, Aurer I, Jordan K, Borsaru G, Pristupa AS, Bosi A, Grosicki S, Glushko NL, Ristic D, Jakucs J, Montesinos P, Mayer J, Rego EM, Baldini S, Scartoni S, Capriati A, Maggi CA, Simonelli C; FLORENCE Study Group

2015

doi: 10.3324/haematol.2015.129577Epub 2015 Jul 9

Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study

Ocio EM, Herrera P, Olave M-T, Castro N, Perez Simon JA, Brunet S, Oriol A, Mateo M, Sanz MA, López J, Montesinos P, Chillón MC, Prieto-Conde M-I, Díez-Campelo M, González M, Vídriales M-B, Mateos M-V, San Miguel JF, PETHEMA Group

2015

doi: 10.1111/bjh.13355

Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations

dema V, Larráyoz MJ, Calasanz MJ, Palomo L, Patiño-García A, Agirre X, Hernández-Rivas JM, Lumbreras E, Buño I, Martinez-Laperche C, Mallo M, García O, Álvarez S, Blazquez B, Cervera J, Luño E, Valiente A, Vallespí MT, Arenillas L, Collado R, Pérez-Oteyza J, Solé F

2015

doi: 10.1038/leu.2015.115Epub 2015 May 6

Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry.

Bernal T, Martínez-Camblor P, Sánchez-García J, de Paz R, Luño E, Nomdedeu B, Ardanaz MT, Pedro C, Amigo ML, Xicoy B, del Cañizo C, Tormo M, Bargay J, Valcárcel D, Brunet S, Benlloch L, Sanz G; Spanish Group on Myelodysplastic Syndromes; PETHEMA Foundation; Spanish Society of Hematology

2015

doi: 10.1038/leu.2015.98Epub 2015 Apr 17

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. Leukemia

Ruggeri A, Labopin M, Sanz G, Piemontese S, Arcese W, Bacigalupo A, Blaise D, Bosi A, Huang H, Karakasis D, Koc Y, Michallet M, Picardi A, Sanz J, Santarone S, Sengelov H, Sierra J, Vincent L, Volt F, Nagler A, Gluckman E, Ciceri F, Rocha V, Mohty M; Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology working party-EBMT; ALWP-EBMT study

2015

doi: 10.1179/1607845415Y.0000000003

Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3

Raya JM, Martín-Santos T, Luño E, Sanzo C, Perez-Sirvent ML, Such E, Navarro JT, Millá F, Alonso E, Domingo A, Rozman M, Díaz-Beva M, Batlle A, González-de-Villambrosia S, Tuset E, Vallespí T, Ortega M, Bermejo A, Martín-Ramos M, Peri V, Solé F, Florensa L; Grupo Español de Citología Hematológica (GECH), Working Group into the Sociedad Española de Hematología y Hemoterapia (SEHH)

2015

doi: 10.1016/j.jgo.2015.03.003

Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale

Bonanad S, De la Rubia J, Gironella M, Pérez Persona E, González B, Fernández Lago C, Arnan M, Zudaire M, Hernández Rivas JA, Soler A, Marrero C, Olivier C, Altés A, Valcárcel D, Hernández MT, Oiartzabal I, Fernández Ordoño R, Arnao M, Esquerra A, Sarrá J, González-Barca E, González J, Calvo X, Nomdedeu M, García Guiñón A, Ramírez Payer A, Casado A, López S, Durán M, Marcos M, Cruz-Jentoft AJ

2015

doi: 10.1016/j.exphem.2015.06.209

Declined presentation defining hematopoietic stem cell subtypes and their role in hematopoietic regeneration and ageing

Amit Grover, Alejandra Sanjuan-Pla, Joana de Teixeira Carelha, Supat Thongjuea, Sten Eirik W. Jacobsen, Claus Nerlov

2015

doi: 10.1111/bjh.13450Epub 2015 Apr 24

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry. Br J Haematol

de Swart L, Smith A, Johnston TW, Haase D, Droste J, Fenaux P, Symeonidis A, Sanz G, Hellström-Lindberg E, Cermák J, Germing U, Stauder R, Georgescu O, MacKenzie M, Malcovati L, Holm MS, Almeida AM, Madry K, Slama B, Guerci-Bresler A, Sanhes L, Beyne-Rauzy O, Luño E, Bowen D, de Witte T

2015

doi: 10.1007/s00277-015-2393-0Epub 2015 May 15

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

Sanz MA, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martinez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vellenga E, Holowiecka A, González-Huerta AJ, Fernandez P, la Serna de J, Brunet S, de Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM, IC-APL and PETHEMA and HOVON Groups

2015

doi: 10.1007/s00277-015-2372-5Epub 2015 Apr 25

Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia

Sanz MA, Montesinos P, Casale MF, Díaz-Mediavilla J, Jimenez S, Fernández I, Fernandez P, González-Campos J, González JD, Herrera P, de Lisa E, Olave T, Rojas R, Salamero O, Sayas MJ, Pellicer A, Perales A

2015

doi: 10.18632/oncotarget.4146

Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms accordingto their maturation-associated immunophenotypic profile

Martín-Martín L, López A, Vidriales B, Caballero MD, Rodrigues AS, Ferreira SI, Lima M, Almeida S, Valverde B, Martínez P, Ferrer A, Candeias J, Ruíz-Cabello F, Buadesa JM, Sempere A, Villamor N, Orfao A, Almeida J

2015

doi: 10.1016/j.riam.2014.10.003Epub 2015 Feb 20

Treatment of invasive fungal disease using anidulafungin alone or in combination for hematologic patients with concomitant hepatic or renal impairment.

Montesinos P, Rodríguez-Veiga R, Martínez-Cuadrón D, Boluda B, Navarro I, Vera B, Alonso CM, Sanz J, López-Chulia F, Martín G, Jannone R, Sanz G, Lancharro A, Cano I, Palau J, Lorenzo I, Jarque I, Salavert M, Ramírez P, Sanz MÁ

2015

doi: 10.2450/2015.0195-14Epub 2015 Feb 2

Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation.

Solves P, Carpio N, Balaguer A, Romero S, Iacoboni G, Gómez I, Lorenzo I, Moscardó F, Sanz J, Lopez F, Martin G, Jarque I, Montesinos P, De La Rubia J, Sanz G, Sanz MA

2015

doi: 10.1038/leu.2015.55Epub 2015 Feb 27

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM). Leukemia

Della Porta MG, Tuechler H, Malcovati L, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres MA, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D, Greenberg PL, Cazzola M

2015

doi: 10.2450/2015.0148-14Epub 2015 Apr 28

Passenger lymphocyte syndrome in liver transplant recipients: a description of 12 cases

Romero S, Solves P, Lancharro A, Cano I, Moscardo F, Carpio N, Sanz MA

2015

doi: 10.1055/s-0035-1549316

Normal shoulder MRI and MR arthrography: Anatomy and technique

Llopis E, Montesinos P, Guedez MT, Aguilella L, Cerezal L

2015

doi: 10.1016/S2352-3026(15)00067-8Epub 2015 May 20

Use of newer prognostic indices for patients with myelodysplastic syndromes in the low and intermediate-1 risk categories: a population-based study.

Valcárcel D, Sanz G, Ortega M, Nomdedeu B, Luño E, Diez-Campelo M, Ardanaz MT, Pedro C, Montoro J, Collado R, Andreu R, Marco V, Cedena MT, de Paz R, Tormo M, Xicoy B, Ramos F, Bargay J, Gonzalez B, Brunet S, Muñoz JA, Gomez V, Bailén A, Sanchez J, Merchán B, del Cañizo C, Vallespí T; Grupo Español de Síndromes Mielodisplásicos (GESMD)

2015

doi: PMCID: PMC4548346

Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine

Murria R, Palanca S, de Juan I, Alenda C, Egoavil C, Seguí FJ, García-Casado Z, Juan MJ, Sánchez AB, Segura Á, Santaballa A, Chirivella I, Llop M, Pérez G, Barragán E, Salas D, Bolufer P

2015

doi: 10.1007/s00277-015-2305-3

Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis

Vallejo C, Montesinos P, Polo M, Cuevas B, Morado M, Rosell A, Xicoy B, Díez JL, Salamero O, Cedillo Á, Martínez P, Rayón C

2015

doi: 10.1182/blood-2015-04-638742

Critical Analysis of the Stringent Complete Response in Multiple Myeloma: Contribution of sFLC and Bone Marrow Clonality

Martínez-López J, Paiva B, López-Anglada L, Mateos MV, Cedena T, Vidríales MB, Sáez-Gómez MA, Contreras T, Oriol A, Rapado I, Teruel AI, Cordón L, Blanchard MJ, Bengoechea E, Palomera L, de Arriba F, Cueto-Felgueroso C, Orfao A, Bladé J, San Miguel JF, Lahuerta JJ; Spanish Multiple Myeloma Group / Program for the Study of Malignant Blood Diseases Therapeutics (GEM / PETHEMA) Cooperative Study Group. Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality.

2015

doi: 10.1007/s00277-014-2274-yEpub 2014 Dec 18

Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications. Ann Hematol

Remacha ÁF, Arrizabalaga B, Villegas A, Durán MS, Hermosín L, de Paz R, Garcia M, Diez Campelo M, Sanz G; IRON-2 Study Group

2015

doi: 10.3324/haematol.2014.118117Epub 2015 Jan 30

CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia

Barragán E, Chillón MC, Castelló-Cros R, Marcotegui N, Prieto MI, Hoyos M, Pippa R, Llop M, Etxabe A, Cervera J, Rodríguez G, Buño I, Rifón J, Sierra J, González M, Calasanz MJ, Sanz MA, Odero MD

2015

doi: 10.3324/haematol.2014.119339Epub 2015 Mar 13

The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Rubio MT, Labopin M, Blaise D, Socié G, Contreras RR, Chevallier P, Sanz MA, Vigouroux S, Huynh A, Shimoni A, Bulabois C-E, Caminos N, López-Corral L, Nagler A, Mohty M

2015

doi: 10.1038/leu.2015.12Epub 2015 Jan 28

Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet

Lengfelder E, Coco Lo F, Adès L, Montesinos P, Grimwade D, Kishore B, Ramadan SM, Pagoni M, Breccia M, Huerta AJG, Nloga AM, González-San Miguel JD, Schmidt A, Lambert J-F, Lehmann S, Di Bona E, Cassinat B, Hofmann W-K, Görlich D, Sauerland M-C, Fenaux P, Sanz M

2015

doi: 10.1016/j.bbmt.2014.12.038Epub 2015 Jan 10

Bloodstream infections in adult patients undergoing cord blood transplantation from unrelated donors after myeloablative conditioning regimen.

Sanz J, Cano I, González-Barberá EM, Arango M, Reyes J, Montesinos P, Lorenzo I, Jarque I, Martínez J, López F, Arilla MJ, Lancharro A, Moscardó F, López-Hontangas JL, Salavert M, Sanz MA, Sanz GF

2015

doi: 10.3324/haematol.2014.111450Epub 2015 Jan 30

T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis

Gorin N-C, Labopin M, Piemontese S, Arcese W, Santarone S, Huang H, Meloni G, Ferrara F, Beelen D, Sanz M, Bacigalupo A, Ciceri F, Mailhol A, Nagler A, Mohty M, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

2015

doi: 10.1038/tpj.2014.80Epub 2015 Jan 6

Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies

Megías-Vericat JE, Rojas L, Herrero MJ, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MA, Aliño SF

2015

doi: 10.1111/bjh.13266

Use of eltrombopag after romiplostim in primary immune thrombocytopenia

González-Porras JR, Mingot-Castellano ME, Andrade MM, Alonso R, Caparrós I, Arratibel MC, Fernández-Fuertes F, Cortti MJ, Pascual C, Sánchez-González B, Bernat S, Fuertes-Palacio MA, Vázquez-Paganini JA, Olivera PE, Alvarez-Román MT, Jarque I, Cortés M, Martínez-Robles V, Díaz-Gálvez FJ, Calbacho M, Fernández-Miñano C, Garcia-Frade J, González-López TJ

2015

doi: 10.1182/blood-2014-10-607341Epub 2015 Jan 26

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. Blood

Savona MR, Malcovati L, Komrokji R, Tiu RV, Mughal TI, Orazi A, Kiladjian JJ, Padron E, Solary E, Tibes R, Itzykson R, Cazzola M, Mesa R, Maciejewski J, Fenaux P, Garcia-Manero G, Gerds A, Sanz G, Niemeyer CM, Cervantes F, Germing U, Cross NC, List AF; MDS/MPN International Working Group

2015

doi: 10.1016/j.bbmt.2014.11.675Epub 2014 Dec 19

Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party. Biol Blood Marrow Transplant

Robin M, Ruggeri A, Labopin M, Niederwieser D, Tabrizi R, Sanz G, Bourhis JH, van Biezen A, Koenecke C, Blaise D, Tischer J, Craddock C, Maillard N, Mohty M, Russel N, Schetelig J, Finke J, Gluckman E, de Witte TM, Rocha V, Kroger N

2015

doi: 10.3109/10428194.2015.1014365

Impact of transplant eligibility and availability of a human leukocyte antigen-identical matched related donor on outcome of older patients with acute lymphoblastic leukemia.

Barba P, Martino R, Martinez-Cuadron D, Olga G, Esquirol A, Gil-Cortés C, Gonzalez J, Fernandez-Avilés F, Valcárcel D, Guardia R, Duarte RF, Hernandez-Rivas JM, Abella E, Montesinos P, Ribera JM.

2015

doi: 10.1038/bcj.2015.11

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes

McGraw KL, Zhang LM, Rollison DE, Basiorka AA, Fulp W, Rawal B, Jerez A, Billingsley DL, Lin HY, Kurtin SE, Yoder S, Zhang Y, Guinta K, Mallo M, Solé F, Calasanz MJ, Cervera J, Such E, González T, Nevill TJ, Haferlach T, Smith AE, Kulasekararaj A, Mufti G, Karsan A, Maciejewski JP, Sokol L, Epling-Burnette PK, Wei S, List AF

2015

doi: 10.1002/ajh.23900

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

González-López TJ, Pascual C, Álvarez-Román MT, Fernández-Fuertes F,Sánchez-González B, Caparrós I, Jarque I, Mingot-Castellano ME, Hernández-Rivas JA, Martín-Salces M, Solán L, Beneit P, Jiménez R, Bernat S, Andrade MM, Cortés M, Cortti MJ, Pérez-Crespo S, Gómez-Núñez M, Olivera PE, Pérez-Rus G, Martínez-Robles V, Alonso R, Fernández-Rodríguez A, Arratibel MC, Perera M, Fernández-Miñano C, Fuertes-Palacio MA, Vázquez-Paganini JA, Gutierrez-Jomarrón I, Valcarce I, de Cabo E, Sainz A, Fisac R, Aguilar C, Paz Martínez-Badas M, Peñarrubia MJ, Calbacho M, de Cos C, González-Silva M, Coria E, Alonso A, Casaus A, Luaña A, Galán P, Fernández-Canal C, Garcia-Frade J, González-Porras JR

2015

doi: 10.1016/j.transci.2014.11.005Epub 2014 Nov 13

Quality of thawed plasma inactivated with methylene blue after 48-hour storage

Balaguer A, Moret A, Solves P, Bonanad S, Carpio N, Sanz MA

2015

doi: 10.3109/10428194.2014.930849

Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

Ferrà C, Sanz J, Díaz-Pérez MA, Morgades M, Gayoso J, Cabrera JR, Villaescusa T, Sampol MA, Fernández-Avilés F, Solano C, Ortín M, Duarte R, Cuesta M, Heras I, de la Serna J, Moraleda JM, Barrenetxea C, González-Vicent M, Sanz G, Ribera JM; Grupo Español de Trasplante Hematopoyético (Geth) Spanish Society of Hematology.

2015

doi: 10.1016/j.anai.2014.11.019

Syncope as a manifestation of mast cell activation disorder

Perales Chordá C, Fabregat Nebot S, Moral Moral P, Jarque Ramos I, Hernández Fernandez de Rojas D

2015

doi: 10.1016/j.leukres.2014.10.004Epub 2014 Oct 30

Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score.

Falantes J, Delgado RG, Calderón-Cabrera C, Márquez-Malaver FJ, Valcarcel D, de Miguel D, Bailén A, Bargay J, Bernal T, González-Porras JR, Tormo M, Ramos F, Andreu R, Xicoy B, Nomdedeu B, Brunet S, Sánchez J, Jurado AF, Bonanad S, Pérez-Simón JA, Sanz G; Spanish Group of Myelodysplastic Syndromes (GESMD)

2015

doi: 10.1182/blood-2015-01-623330Epub 2015 Oct 1

High Delta Np73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia

Lucena-Araujo AR, Kim HT, Thomé C, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Glória ABF, Chauffaille M de L, Athayde M, Chiattone CS, Mito I, Bendlin R, Souza C, Bortolheiro C, Coelho-Silva JL, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM

2015

doi: 10.3109/10428194.2015.1028053Epub 2015 May 12

Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes

Sánchez-Castro J, Marco-Betés V, Gómez-Arbonés X, García-Cerecedo T, López R, Talavera E, Fernández-Ruiz S, Ademà V, Marugan I, Luño E, Sanzo C, Vallespí T, Arenillas L, Marco Buades J, Batlle A, Buño I, Martín Ramos ML, Blázquez Rios B, Collado Nieto R, Vargas MT, González Martínez T, Sanz G, Solé F; Spanish Group for MDS Study (GESMD); Spanish Group for Clinical Cytogenetics (Gcecgh)

2015

doi: 10.1186/s13045-015-0207-4

Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood-a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation

Baron, Frederic; Labopin, Myriam; Ruggeri, Annalisa; Mohty, Mohamad; Sanz, Guillermo; Milpied, Noel; Bacigalupo, Andrea; Rambaldi, Alessandro; Bonifazi, Francesca; Bosi, Alberto; Sierra, Jorge; Yakoub-Agha, Ibrahim; Ribera Santasusana, Josep Maria; Gluckman, Eliane; Nagler, Arnon

2015

doi: 10.2147/OTT.S80879

Primary paraesophageal Ewing’s sarcoma: an uncommon case report and literature review

Noelia Tarazona, Lara Navarro, Juan Miguel Cejalvo, Valentina Gambardella, J Alejandro Pérez-Fidalgo, Alejo Sempere, Samuel Navarro, and Andrés Cervantes

2015

doi: 0.1182/blood.V126.23.510.510

Elotuzumab plus bortezomib and dexamethasone (EBd) versus bortezomib and dexamethasone (Bd) in patients (Pts) with relapsed/refractory multiple myeloma (RRMM)-2-year follow-up

Antonio Palumbo, MD , Massimo Offidani, MD , Brigitte Pégourie , Javier De La Rubia , Laurent Garderet, MD , Kamel Laribi , Alberto Bosi, MD , Roberto Marasca, MD , Jacob P. Laubach, MD , Ann Mohrbacher, MD , Angelo Michele Carella, MD , Anil K. Singhal , Mark Lynch , Ying-Ming Jou , Andrzej Jakubowiak, MD PhD

2014

doi: 10.1007/s00277-014-2142-9Epub 2014 Jul 2

Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study

Lucena-Araujo AR, Kim HT, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille M de L, Chiattone CS, Lima AS, Ruiz-Argüelles G, Undurraga MS, Martinez L, Kwaan HC, Gallagher R, Niemeyer CM, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM

2014

doi: PMCID: PMC4300703

Methylation of tumor suppressor genes is related with copy number aberrations in breast cance

Rosa Murria, Sarai Palanca, Inmaculada de Juan, Cecilia Egoavil, Cristina Alenda, Zaida García-Casado, María J Juan, Ana B Sánchez, Ana Santaballa, Isabel Chirivella, Ángel Segura, David Hervás, Marta Llop, Eva Barragán, and Pascual Bolufer

2014

doi: 10.1002/cncr.28950.

Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.

Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, González-Campos J, Fernández-Abellán P, Tormo M, Bethencourt C, Brunet S, Hernández-Rivas JM, Moreno MJ, Sarrà J, Del Potro E, Barba P, Bernal T, Grande C, Grau J, Cervera J, Feliu E; PETHEMA Group

2014

doi: 10.1016/j.leukres.2014.12.013

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: clinical use and outcome prediction

Ramos F, Thépot S, Pleyer L, Maurillo L, Itzykson R, Bargay J, Stauder R, Venditti A, Seegers V, Martínez-Robles V, Burgstaller S, Récher C, Debén G, Gaidano G, Gardin C, Musto P, Greil R, Sánchez-Guijo F, Fenaux P

2014

doi: https://pubmed.ncbi.nlm.nih.gov/24728721/

In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene

Such E, Cordón L, Sempere A, Villamón E, Ibáñez M, Luna I, Gómez-Seguí I, López-Pavía M, Alonso C, Lo-Coco F, Cervera J, Sanz MA

2014

doi: 10.1016/j.bbmt.2014.06.038

Effect of CD8+ cell content on umbilical cord blood transplantation in adults with hematological malignancies

Moscardo F, Sanz J, Carbonell F, Sanz MA, Larrea L, Montesinos P, Lorenzo I, Vera B, Boluda B, Salazar C, Canigral C, Planelles D, Jarque I, Solves P, Martin G, López F, la Rubia de J, Martínez J, Carpio N, Martínez-Cuadrón D, Puig N, Montoro JA, Roig R, Sanz GF

2014

doi: 10.3324/haematol.2014.105908

Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

Vallejo C, Batlle M, Vázquez L, Solano C, Sampol A, Duarte R, Hernández D, López J, Rovira M, Jiménez S, Valcárcel D, Belloch V, Jiménez M, Jarque I

2014

doi: 10.1186/2050-6511-15-52

Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain

Ostermann H, Solano C, Jarque I, Garcia-Vidal C, Gao X, Barrueta JA, De Salas-Cansado M, Stephens J, Xue M, Weber B, Charbonneau C

2014

doi: 10.1007/s00277-013-1970-3

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome

Canigral C, Moscardo F, Castro C, Pajares A, Lancharro A, Solves P, la Rubia de J, Carpio N, Sanz MA

2014

doi: 10.1038/bmt.2014.107

Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience

Sanz, J.; Arango, M.; Carpio, N.; Montesinos, P.; Moscardo, F.; Martin, G.; Lopez, F.; Jarque, I.; Lorenzo, I.; de la Rubia, J.; Solves, P.; Boluda, B.; Salazar, C.; Canigral, C.; Sanz, M. A.; Sanz, G. F.

2014

doi: 10.1016/j.clml.2013.11.006

Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: a bridge to individualized medicine

Bennett TA, Montesinos P, Moscardo F, Martinez-Cuadron D, Martinez J, Sierra J, García R, de Oteyza JP, Fernandez P, Serrano J, Fernandez A, Herrera P, Gonzalez A, Bethancourt C, Rodriguez-Macias G, Alonso A, Vera JA, Navas B, Lavilla E, Lopez JA, Jimenez S, Simiele A, Vidriales B, Gonzalez BJ, Burgaleta C, Hernandez Rivas JA, Mascuñano RC, Bautista G, Perez Simon JA, Fuente Ade L, Rayón C, Troconiz IF, Janda A, Bosanquet AG, Hernandez-Campo P, Primo D, Lopez R, Liebana B, Rojas JL, Gorrochategui J, Sanz MA, Ballesteros J

2014

doi: 10.1111/bjh.12876

Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion

Sanchez-Garcia, Joaquin; del Canizo, Consuelo; Lorenzo, Ignacio; Nomdedeu, Benet; Luno, Elisa; de Paz, Raquel; Xicoy, Blanca; Valcarcel, David; Brunet, Salut; Marco-Betes, Victor; Garcia-Pintos, Marta; Osorio, Santiago; Tormo, Mar; Bailen, Alicia; Cervero, Carlos; Ramos, Fernando; Diez-Campelo, Maria; Such, Esperanza; Arrizabalaga, Beatriz; Azaceta, Gemma; Bargay, Joan; Arilla, Maria J.; Falantes, Jose; Serrano-Lopez, Josefina; Sanz, Guillermo F.

2014

doi: 10.3109/10428194.2013.834532

Results of treatment with azacitidine in patients aged >= 75 years included in the Spanish Registry of Myelodysplastic Syndromes

Xicoy, Blanca; Jimenez, Maria-Jose; Garcia, Olga; Bargay, Joan; Martinez-Robles, Violeta; Brunet, Salut; Arilla, Maria-Jesus; Perez de Oteyza, Jaime; Andreu, Rafael; Casano, Francisco-Javier; Cervero, Carlos-Javier; Bailen, Alicia; Diez, Maria; Gonzalez, Bernardo; Vicente, Ana-Isabel; Pedro, Carme; Bernal, Teresa; Luno, Elisa; Cedena, Maria-Teresa; Palomera, Luis; Simiele, Adriana; Calvo, Jose-Manuel; Marco, Victor; Gomez, Eduardo; Gomez, Marta; Gallardo, David; Munoz, Juan; de Paz, Raquel; Grau, Javier; Ribera, Josep-Maria; Benlloch, Luis-Enrique; Sanz, Guillermo

2014

doi: 10.1200/JCO.2013.52.8562

International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia

Roboz GJ, Rosenblat T, Arellano M, Gobbi M, Altman JK, Montesinos P, O'Connell C, Solomon SR, Pigneux A, Vey N, Hills R, Jacobsen TF, Gianella-Borradori A, Foss Ø, Vetrhusand S, Giles FJ

2014

doi: 10.3109/10428194.2013.827187

Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC)

López Rubio M, Da Silva C, Loscertales J, Seri C, Baltasar P, Colado E, Pérez Fernández I, Osma M, Gomis F, González M, Jarque I, Vargas M, Monzó E, Monteagudo D, Orts MI, Pardal E, Carbonell F, Perez Calvo C, Garcia-Marco JA

2014

doi: 10.1200/JCO.2013.52.2425

Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial

Ribera JM, Oriol A, Morgades M, Montesinos P, Sarrà J, González-Campos J, Brunet S, Tormo M, Fernández-Abellán P, Guàrdia R, Bernal MT, Esteve J, Barba P, Moreno MJ, Bermúdez A, Cladera A, Escoda L, García-Boyero R, Del Potro E, Bergua J, Amigo ML, Grande C, Rabuñal MJ, Hernández-Rivas JM, Feliu E

2014

doi: 10.1182/blood-2013-12-544957

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Middeke JM, Fang M, Cornelissen JJ, Mohr B, Appelbaum FR, Stadler M, Sanz J, Baurmann H, Bug G, Schäfer-Eckart K, Hegenbart U, Bochtler T, Röllig C, Stölzel F, Walter RB, Ehninger G, Bornhäuser M, Löwenberg B, Schetelig J

2014

doi: 10.1016/j.fct.2014.01.011

Sister chromatid exchange, (SCE), High-Frequency Cells (HFCs) and SCE distribution patterns in peripheral blood lymphocytes of Spanish adult smokers compared to non-smokers

Sebastià N, Hervás D, Almonacid M, Villaescusa JI, Soriano JM, Sahuquillo V, Esteban V, Barquinero JF, Verdú G, Cervera J, Such E, Montoro

2014

doi: 10.1038/leu.2013.283.

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.

Menezes J, Acquadro F, Wiseman M, Gómez-López G, Salgado RN, Talavera-Casañas JG, Buño I, Cervera JV, Montes-Moreno S, Hernández-Rivas JM, Ayala R, Calasanz MJ, Larrayoz MJ, Brichs LF, Gonzalez-Vicent M, Pisano DG, Piris MA, Álvarez S, Cigudosa JC

2014

doi: 10.1038/leu.2013.259

Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT

Ruggeri A, Sanz G, Bittencourt H, Sanz J, Rambaldi A, Volt F, Yakoub-Agha I, Ribera JM, Mannone L, Sierra J, Mohty M, Solano C, Nabhan S, Arcese W, Gluckman E, Labopin M, Rocha V

2014

doi: 10.1038/bmt.2013.190.

EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases

Sanz J, Arango M, Senent L, Jarque I, Montesinos P, Sempere A, Lorenzo I, Martín G, Moscardó F, Mayordomo E, Salavert M, Canigral C, Boluda B, Salazar C, Lopez-Hontangas JL, Sanz MA, Sanz GF

2014

doi: 10.1111/bjh.12676

Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: A multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study

Redondo AM, Pomares H, Vidal MJ, Pascual MJ, Quereda B, Sancho JM, Polo M, López J, Conde E, Jarque I, Alonso N, Ramírez MJ, Fernández P, Sayas MJ, Requena MJ, Salar A, González JD, González-Barca E, Arranz R, Caballero D, Martín A

2014

doi: 10.3324/haematol.2013.093450

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

Briones J, Novelli S, García-Marco JA, Tomás JF, Bernal T, Grande C, Canales MA, Torres A, Moraleda JM, Panizo C, Jarque I, Palmero F, Hernández M, González-Barca E, López D, Caballero D

2014

doi: 10.3324/haematol.2013.091009

Umbilical cord blood transplantation from unrelated donors in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Luis Pinana, Jose; Sanz, Jaime; Picardi, Alessandra; Ferra, Christelle; Martino, Rodrigo; Barba, Pere; Gonzalez-Vicent, Marta; Jesus Pascual, Maria; Martin, Carmen; Verdeguer, Amparo; Diaz de Heredia, Cristina; Montesinos, Pau; Ribera, Jose-Maria; Sanz, Miguel; Arcese, William; Sanz, Guillermo

2014

doi: 10.1371/journal.pone.0100245. eCollection 2014

Single-nucleotide polymorphism array-based karyotyping of acute promyelocytic leukemia

Gómez-Seguí I, Sánchez-Izquierdo D, Barragán E, Such E, Luna I, López-Pavía M, Ibáñez M, Villamón E, Alonso C, Martín I, Llop M, Dolz S, Fuster Ó, Montesinos P, Cañigral C, Boluda B, Salazar C, Cervera J, Sanz MA

2014

doi: 10.1007/s00277-013-1914-y

Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia

Martínez-Cuadrón D, Montesinos P, Oriol A, Salamero O, Vidriales B, Bergua J, Herrera P, Vives S, Sanz J, Carpio C, Rodríguez-Veiga R, Moscardo F, Sanz MA

2014

doi: 10.1007/s00277-013-1872-4

Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients

Piñana JL, Montesinos P, Martino R, Vazquez L, Rovira M, López J, Batlle M, Figuera A, Barba P, Lahuerta JJ, Debén G, Perez-Lopez C, García R, Rosique P, Lavilla E, Gascón A, Martínez-Cuadrón D, Sanz MA

2014

doi: 10.1016/j.bbmt.2013.10.016

Impact on Outcomes of Human Leukocyte Antigen Matching by Allele-Level Typing in Adults with Acute Myeloid Leukemia Undergoing Umbilical Cord Blood Transplantation

Sanz, Jaime; Jaramillo, Francisco J.; Planelles, Dolores; Montesinos, Pau; Lorenzo, Ignacio; Moscardo, Federico; Martin, Guillermo; Lopez, Francisca; Martinez, Jesus; Jarque, Isidro; de la Rubia, Javier; Larrea, Luis; Sanz, Miguel A.; Sanz, Guillermo F.

2014

doi: 10.3233/CH-131717

Erythrocyte deformability and aggregation in homozygous sickle cell disease

Vayá A, Collado S, Dasí MA, Pérez ML, Hernandez JL, Barragán E

2014

doi: 10.1155/2014/620682

Impact of Cyclosporine Levels on the Development of Acute Graft versus Host Disease after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

García Cadenas I, Valcarcel D, Martino R, Piñana JL, Barba P, Novelli S, Esquirol A, Garrido A, Saavedra S, Granell M, Moreno C, Briones J, Brunet S, Sierra J

2014

Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study

Lucena-Araujo AR, Kim HT, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, de Lourdes Chauffaille M, Chiattone CS, Lima AS, Kwaan HC, Gallagher R, Niemeyer CM, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM

2014

Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Nagler A, Labopin M, Gorin N-C, Ferrara F, Sanz MA, Wu D, Gomez AT, Lapusan S, Irrera G, Guimaraes JE, Sousa AB, Carella AM, Vey N, Arcese W, Shimoni A, Berger R, Rocha V, Mohty M

2014

doi: 10.3324/haematol.2014.109280

Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen

Ruggeri, Annalisa; Labopin, Myriam; Sormani, Maria Pia; Sanz, Guillermo; Sanz, Jaime; Volt, Fernanda; Michel, Gerard; Locatelli, Franco; Diaz De Heredia, Cristina; O'Brien, Tracey; Arcese, William; Iori, Anna Paola; Querol, Sergi; Kogler, Gesine; Lecchi, Lucilla; Pouthier, Fabienne; Garnier, Federico; Navarrete, Cristina; Baudoux, Etienne; Fernandes, Juliana; Kenzey, Chantal; Eapen, Mary; Gluckman, Eliane; Rocha, Vanderson; Saccardi, Riccardo

2014

doi: 10.1038/bmt.2013.120

Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis

Cunha, R.; Loiseau, P.; Ruggeri, A.; Sanz, G.; Michel, G.; Paolalori, A.; Socie, G.; Arcese, W.; Picardi, A.; Dias de Heredia, C.; Rio, B.; Locatelli, F.; O'Brien, T. A.; Yakoub-Agha, I.; Angel Diaz, M.; Milpied, N.; Bittencourt, H.; Pedro Souza, M.; Aljurf, M.; Charron, D.; Boudjedir, K.; Labopin, M.; Gluckman, E.; Rocha, V.

2014

doi: 10.1111/bjh.12970

Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation

Tucunduva, Luciana; Ruggeri, Annalisa; Sanz, Guillermo; Furst, Sabine; Cornelissen, Jan; Linkesch, Werner; Mannone, Lionel; Ribera, Josep-Maria; Veelken, Hendrik; Yakoub-Agha, Ibrahim; Gonzalez Valentin, Maria Elvira; Schots, Rik; Arcese, William; Montesinos, Pau; Labopin, Myriam; Gluckman, Eliane; Mohty, Mohamad; Rocha, Vanderson

2014

doi: 10.1093/annonc/mdu180

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Fenaux, P.; Haase, D.; Sanz, G. F.; Santini, V.; Buske, C.

2014

doi: 10.1111/ejh.12380

Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

Giagounidis, Aristoteles; Mufti, Ghulam J.; Mittelman, Moshe; Sanz, Guillermo; Platzbecker, Uwe; Muus, Petra; Selleslag, Dominik; Beyne-Rauzy, Odile; te Boekhorst, Peter; del Canizo, Consuelo; Guerci-Bresler, Agnes; Nilsson, Lars; Luebbert, Michael; Quesnel, Bruno; Ganser, Arnold; Bowen, David; Schlegelberger, Brigitte; Goehring, Gudrun; Fu, Tommy; Benettaib, Bouchra; Hellstrom-Lindberg, Eva; Fenaux, Pierre

2014

doi: 10.3324/haematol.2013.098103

p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

Saft, Leonie; Karimi, Mohsen; Ghaderi, Mehran; Matolcsy, Andras; Mufti, Ghulam J.; Kulasekararaj, Austin; Goehring, Gudrun; Giagounidis, Aristoteles; Selleslag, Dominik; Muus, Petra; Sanz, Guillermo; Mittelman, Moshe; Bowen, David; Porwit, Anna; Fu, Tommy; Backstrom, Jay; Fenaux, Pierre; MacBeth, Kyle J.; Hellstrom-Lindberg, Eva

2014

doi: 10.1016/j.leukres.2014.07.009

Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients

Diez Campelo, M.; Sanchez-Barba, M.; de Soria, V. Gomez-Garcia; Martino, R.; Sanz, G.; Insunza, A.; Bernal, T.; Duarte, R.; Amigo, M. L.; Xicoy, B.; Tormo, M.; Iniesta, F.; Bailen, A.; Benlloch, L.; Cordoba, I.; Lopez-Villar, O.; del Canizo, M. C.

2014

doi: 10.1038/bmt.2014.72

Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Tucunduva, L.; Ruggeri, A.; Sanz, G.; Furst, S.; Socie, G.; Michallet, M.; Arcese, W.; Milpied, N.; Yakoub-Agha, I.; Linkesch, W.; Cornelissen, J.; Mannone, L.; Iori, A. P.; Ribera, J-M; Sanz, J.; Montesinos, P.; Purtill, D.; Labopin, M.; Gluckman, E.; Mohty, M.; Rocha, V.

2014

doi: 10.1016/j.bbmt.2014.06.011

Unrelated Cord Blood Transplantation for Patients with Primary or Secondary Myelofibrosis

Robin, Marie; Giannotti, Federica; Deconinck, Eric; Mohty, Mohamad; Michallet, Mauricette; Sanz, Guillermo; Chevallier, Patrice; Cahn, Jean-Yves; Legrand, Faezeh; Rovira, Montserrat; Passweg, Jakob; Sierra, Jorge; Nguyen, Stephanie; Maillard, Natacha; Yakoub-Agha, Ibrahim; Linkesch, Werner; Cannell, Paul; Marcatti, Magda; Bay, Jacques-Olivier; Chalandon, Yves; Kroger, Nicolaus; Gluckman, Eliane; Rocha, Vanderson; Olavarria, Eduardo; Ruggeri, Annalisa

2014

doi: 10.1038/bcj.2014.62

Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)

Sekeres, M. A.; Swern, A. S.; Fenaux, P.; Greenberg, P. L.; Sanz, G. F.; Bennett, J. M.; Dreyfus, F.; List, A. F.; Li, J. S.; Sugrue, M. M.

2013

doi: 10.1182/blood-2013-05-502773

Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia

Abrisqueta P, Villamor N, Terol MJ, González-Barca E, González M, Ferrà C, Abella E, Delgado J, García-Marco JA, González Y, Carbonell F, Ferrer S, Monzó E, Jarque I, Muntañola A, Constants M, Escoda L, Calvo X, Bobillo S, Montoro JB, Montserrat E, Bosch F

2013

doi: 10.1186/cc13172

Survival of hematological patients after discharge from the intensive care unit: a prospective observational study

Bernal T, Pardavila EV, Bonastre J, Jarque I, Borges M, Bargay J, Ayestarán JI, Insausti J, Marcos P, González-Sanz V, Martínez-Camblor P, Albaiceta GM

2013

doi: 10.3109/09553002.2013.809172

Frequency of dicentrics and contamination levels in ukrainian children and adolescents from areas near chernobyl 20 years after the nuclear plant accident

Montoro A, Sebastià N, Candela-Juan C, Barquinero JF, Soriano JM, Almonacid M, Alonso O, Guasp M, Marques-Sule E, Cervera J, Such E, Arnal C, Villaescusa JI.

2013

doi: 10.1038/leu.2013.187

Monosomal karyotype in MDS: explaining the poor prognosis?

Schanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, Grau J, Hildebrandt B, Slovak ML, Ohyashiki K, Steidl C, Fonatsch C, Pfeilstöcker M, Nösslinger T, Valent P, Giagounidis A, Aul C, Lübbert M, Stauder R, Krieger O, Le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D.

2013

doi: 10.1007/s10549-013-2723-7

MicroRNA signatures in hereditary breast cancer

Murria Estal R, Palanca Suela S, de Juan Jiménez I, Egoavil Rojas C, García-Casado Z, Juan Fita MJ, Sánchez Heras AB, Segura Huerta A, Chirivella González I, Sánchez-Izquierdo D, Llop García M, Barragán González E, Bolufer Gilabert P

2013

doi: 10.3109/09273948.2013.801993

CD4/CD8 ratio in aqueous humor in uveitis

Sanz-Marco E, Garces M, Sempere A, Diaz-Llopis M

2013

doi: 10.1038/leu.2013.166

A Multiparameter Flow Cytometry Immunophenotypic Algorithm for the Identification of Newly Diagnosed Symptomatic Myeloma With an MGUS-like Signature and Long-Term Disease Control

Paiva B, Vídriales MB, Rosiñol L, Martínez-López J, Mateos MV, Ocio EM, Montalbán MÁ, Cordón L, Gutiérrez NC, Corchete L, Oriol A, Terol MJ, Echeveste MA, De Paz R, De Arriba F, Palomera L, de la Rubia J, Díaz-Mediavilla J, Granell M, Gorosquieta A, Alegre A, Orfao A, Lahuerta JJ, Bladé J, San Miguel JF; Grupo Español de MM/Programa para el Estudio de la Terapéutica en Hemopatías Malignas Cooperative Study Group.

2013

doi: 10.1038/nature12495

Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy

Alejandra Sanjuan-Pla, Iain C. Macaulay, Christina T. Jensen, Petter S. Woll, Tiago C. Luis, Adam Mead, Susan Moore, Cintia Carella, Sahoko Matsuoka, Tiphaine Bouriez Jones, Onima Chowdhury, Laura Stenson, Michael Lutteropp, Joanna C. A. Green, Raffaella Facchini, Hanane Boukarabila, Amit Grover, Adriana Gambardella, Supat Thongjuea, Joana Carrelha, Paul Tarrant, Deborah Atkinson, Sally-Ann Clark, Claus Nerlov & Sten Eirik W. Jacobsen

2012

doi: 10.1111/bjh.12354

Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.

Mallo M, Del Rey M, Ibáñez M, Calasanz MJ, Arenillas L, Larráyoz MJ, Pedro C, Jerez A, Maciejewski J, Costa D, Nomdedeu M, Diez-Campelo M, Lumbreras E, González-Martínez T, Marugán I, Such E, Cervera J, Cigudosa JC, Alvarez S, Florensa L, Hernández JM, Solé F

2013

doi: 10.1002/cncr.27918

Dose-intensive chemotherapy including rituximab in Burkitt’s leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab)

Ribera JM, García O, Grande C, Esteve J, Oriol A, Bergua J, González-Campos J, Vall-Llovera F, Tormo M, Hernández-Rivas JM, García D, Brunet S, Alonso N, Barba P, Miralles P, Llorente A, Montesinos P, Moreno MJ, Hernández-Rivas JÁ, Bernal T

2013

doi: 10.1016/j.leukres.2012.12.010

Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does -7/7q- detection by FISH have prognostic value?

Ademà V, Hernández JM, Abáigar M, Lumbreras E, Such E, Calull A, Dominguez E, Arenillas L, Mallo M, Cervera J, Marugán I, Tormo M, García F, González T, Luño E, Sanzo C, Martín ML, Fernández M, Costa D, Blázquez B, Barreña B, Marco F, Batlle A, Buño I, Martínez-Laperche C, Noriega V, Collado R, Ivars D, Carbonell F, Vallcorba I, Melero J, Delgado E, Vargas MT, Grau J, Salido M, Espinet B, Melero C, Florensa L, Pedro C, Solé F.

2013

doi: 10.1007/s10689-012-9579-6

The deletion of exons 3-5 of BRCA1 is the first founder rearrangement identified in breast and/orovarian cancer Spanish families

Palanca S, de Juan I, Perez-Simó G, Barragán E, Chirivella I, Martínez E, Fuster O, Bolufer P

2013

doi: 23546466

Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles

De la Serna J, Jarque I, López-Jiménez J, Fernández-Navarro JM, Gómez V, Jurado M, Pascual A, Serrano J, Romero M, Vallejo C

2013

doi: 10.1182/blood-2012-07-445965

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

Daikeler T, Labopin M, Ruggeri A, Crotta A, Abinun M, Hussein AA, Carlson K, Cornillon J, Diez-Martin JL, Gandemer V, Faraci M, Lindemans C, O'Meara A, Mialou V, Renard M, Sedlacek P, Sirvent A, Socié G, Sora F, Varotto S, Sanz J, Voswinkel J, Vora A, Yesilipek MA, Herr AL, Gluckman E, Farge D, Rocha V

2013

doi: 10.1016/j.fct.2012.10.013

Radioprotective activity and cytogenetic effect of resveratrol in human lymphocytes: An in vitro evaluation

Sebastià N, Almonacid M, Villaescusa JI, Cervera J, Such E, Silla MA, Soriano JM, Montoro A

2013

doi: 10.1016/j.bbmt.2012.12.018

Impact of Hyperferritinemia on the Outcome of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies

Barba P, Valcárcel D, Pérez-Simón JA, Fernández-Avilés F, Piñana JL, Martino R, López-Anglada L, Rovira M, Garcia-Cadenas I, Novelli S, Carreras E, López Corral L, Sierra J

2013

Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach

Blanes M, Lahuerta JJ, González JD, Ribas P, Solano C, Alegre A, Bladé J, San Miguel JF, Sanz MA, la Rubia de J

2013

Screening for IDH mutations in chronic myelomonocytic leukemia

Ibáñez M, Such E, Cervera J, Luna I, Gómez-Seguí I, López-Pavía M, Avaria A, Senent ML, Sanz GF, Sanz MA

2013

Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)

Jarque I, Tormo M, Bello JL, Rovira M, Batlle M, Julià A, Tabares S, Rivas C, Fernández-Sevilla A, García-Boyero R, Debén G, González-Campos J, Capote FJ, Sanz MA, Spanish Pethema Group

2013

Cross-sectional validation study of patient-reported outcomes in patients with paroxysmal nocturnal haemoglobinuria

Weitz I, Meyers G, Lamy T, Cahn J-Y, Uranga MT, García Vela JA, Sanz MA, Severino B, Kelly RJ, Hillmen P, Hill A

2013

Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

Rego EM, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MDR, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille M de L, Chiattone CS, Martinez L, Meillón LA, Gómez-Almaguer D, Kwaan HC, Garcés-Eisele J, Gallagher R, Niemeyer CM, Schrier SL, Tallman M, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA

2013

BRAFV600E mutation in adult acute lymphoblastic leukemia

Alonso CM, Such E, Gómez-Seguí I, Cervera J, Martínez-Cuadrón D, Luna I, Ibáñez M, López-Pavía M, Vera B, Navarro I, Senent L, Sanz Alonso MA

2013

Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation

Sanz J, Picardi A, Hernández Boluda JC, Martín C, Ferrá C, Nozzoli C, Gonzalez-Vicent M, Rambaldi A, Valcarcel D, Verdeguer A, Serrano D, de Heredia CD, Pascual MJ, de Paz R, Montesinos P, Bartolozzi B, Algarotti A, Sanz MA, Arcese W, Sanz GF, GETH and GITMO

2013

Novel real-time polymerase chain reaction assay for simultaneous detection of recurrent fusion genes in acute myeloid leukemia

Dolz S, Barragán E, Fuster Ó, Llop M, Cervera J, Such E, De Juan I, Palanca S, Murria R, Bolufer P, Luna I, Gómez I, López M, Ibáñez M, Sanz MA

2013

Acute promyelocytic leukemia: do we have a new front-line standard of treatment

Sanz MA, Iacoboni G, Montesinos P

2013

Results of a preoperative autologous blood donation program for patients undergoing elective major spine surgery

Solves P, Carpio N, Moscardo F, Bas T, Canigral C, Salazar C, Boluda B, Sanz MA

2013

Biology and management of therapy-related acute promyelocytic leukemia

Lo-Coco F, Hasan SK, Montesinos P, Sanz MA

2013

Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms

Sanz J, Wagner JE, Sanz MA, Defor T, Montesinos P, Bachanova V, Lorenzo I, Warlick E, Sanz GF, Brunstein C

2013

Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients

Fuster Ó, Llop M, Dolz S, García P, Such E, Ibáñez M, Luna I, Gómez I, López M, Cervera J, Montesinos P, Moscardo F, Cordón L, Solves P, de Juan I, Palanca S, Bolufer P, Sanz MA, Barragán E

2013

WT1 isoform expression pattern in acute myeloid leukemia

Luna I, Such E, Cervera J, Barragán E, Ibáñez M, Gómez-Seguí I, López-Pavía M, Llop M, Fuster Ó, Dolz S, Oltra S, Alonso C, Vera B, Lorenzo I, Martínez-Cuadrón D, Montesinos P, Senent ML, Moscardo F, Bolufer P, Sanz MA

2013

Impact On Outcomes Of Hla Matching By Allele-Level Typing In Adults With Acute Myeloid Leukemia Undergoing Umbilical Cord Blood Transplantation

Sanz J, Jaramillo FJ, Planelles D, Montesinos P, Lorenzo I, Moscardo F, Martin G, López F, Martínez J, Jarque I, Javier de, la Rubia, Larrea L, Sanz MA, Sanz GF

2013

doi: 10.1016/j.leukres.2013.04.010

Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome

Sanchez-Castro, Judit; Marco-Betes, Victor; Gomez-Arbones, Xavier; Arenillas, Leonor; Valcarcel, David; Vallespi, Teresa; Costa, Dolors; Nomdedeu, Benet; Jose Jimenez, Maria; Granada, Isabel; Grau, Javier; Ardanaz, Maria T.; de la Serna, Javier; Carbonell, Felix; Cervera, Jose; Sierra, Adriana; Luno, Elisa; Cervero, Carlos J.; Falantes, Jose; Calasanz, Maria J.; Gonzalez-Porras, Jose R.; Bailen, Alicia; Luz Amigo, M.; Sanz, Guillermo; Sole, Francesc

2013

doi: 10.1200/JCO.2012.41.6073

Complex, Not Monosomal, Karyotype Is the Cytogenetic Marker of Poorest Prognosis in Patients With Primary Myelodysplastic Syndrome

Valcarcel, David; Adema, Vera; Sole, Francesc; Ortega, Margarita; Nomdedeu, Benet; Sanz, Guillermo; Luno, Elisa; Canizo, Consuelo; de la Serna, Javier; Ardanaz, Maite; Marco, Victor; Collado, Rosa; Grau, Javier; Montoro, Julia; Mallo, Mar; Vallespi, Teresa

2013

doi: 10.1182/blood-2012-08-452938

Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia

Such, Esperanza; Germing, Ulrich; Malcovati, Luca; Cervera, Jose; Kuendgen, Andrea; Della Porta, Matteo G.; Nomdedeu, Benet; Arenillas, Leonor; Luno, Elisa; Xicoy, Blanca; Amigo, Mari L.; Valcarcel, David; Nachtkamp, Kathrin; Ambaglio, Ilaria; Hildebrandt, Barbara; Lorenzo, Ignacio; Cazzola, Mario; Sanz, Guillermo

2013

doi: 10.1182/blood-2013-03-492884

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

Malcovati, Luca; Hellstrom-Lindberg, Eva; Bowen, David; Ades, Lionel; Cermak, Jaroslav; del Canizo, Consuelo; Della Porta, Matteo G.; Fenaux, Pierre; Gattermann, Norbert; Germing, Ulrich; Jansen, Joop H.; Mittelman, Moshe; Mufti, Ghulam; Platzbecker, Uwe; Sanz, Guillermo F.; Selleslag, Dominik; Skov-Holm, Mette; Stauder, Reinhard; Symeonidis, Argiris; van de Loosdrecht, Arjan A.; de Witte, Theo; Cazzola, Mario

2013

doi: 10.1038/leu.2012.369

Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis

Kuendgen, A.; Lauseker, M.; List, A. F.; Fenaux, P.; Giagounidis, A. A.; Brandenburg, N. A.; Backstrom, J.; Glasmacher, A.; Hasford, J.; Germing, U.

2013

doi: 10.1002/gcc.22071

Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: Review of 5,654 patients with an evaluable karyotype

Costa, Dolors; Munoz, Concha; Carrio, Ana; Nomdedeu, Meritxell; Calvo, Xavier; Sole, Francesc; Luno, Elisa; Cervera, Jose; Vallespi, Teresa; Berneaga, Daniela; Gomez, Candida; Arias, Amparo; Such, Esperanza; Sanz, Guillermo; Grau, Javier; Insunza, Andres; Calasanz, Maria J.; Ardanaz, Maria T.; Hernandez, Jesus M.; Azaceta, Gemma; Alvarez, Sara; Sanchez, Joaquin; Martin, Maria L.; Bargay, Joan; Gomez, Valle; Javier Cervero, Carlos; Allegue, Maria J.; Collado, Rosa; Campo, Elias; Nomdedeu, Benet

2013

doi: 10.3324/haematol.2012.071449

Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes

Senent, Leonor; Arenillas, Leonor; Luno, Elisa; Ruiz, Juan C.; Sanz, Guillermo; Florensa, Lourdes

2013

doi: 10.1111/tan.12195

Sequencing of a novel HLA-B allele, B*51:153, in a Spanish individual

Planelles, D.; Balas, A.; Sanz, G. F.; Rodriguez-Cebria, M.; Vicario, J. L.

2013

doi: 10.1002/gcc.22112

Single Nucleotide Polymorphism Array Karyotyping: A Diagnostic and Prognostic Tool in Myelodysplastic Syndromes with Unsuccessful Conventional Cytogenetic Testing

Arenillas, Leonor; Mallo, Mar; Ramos, Fernando; Guinta, Kathryn; Barragan, Eva; Lumbreras, Eva; Larrayoz, Maria-Jose; De Paz, Raquel; Tormo, Mar; Abaigar, Maria; Pedro, Carme; Cervera, Jose; Such, Esperanza; Jose Calasanz, Maria; Diez-Campelo, Maria; Sanz, Guillermo F.; Maria Hernandez, Jesus; Luno, Elisa; Saumell, Silvia; Maciejewski, Jaroslaw; Florensa, Lourdes; Sole, Francesc

2012

doi: 23303265

Antifungal prophylaxis in the haematological patient: a practical approach

Vázquez L, Carreras E, Serrano D, Jarque I, Mensa J, Barberán J

2012

doi: 10.1007/s10689-012-9563-1

Low penetrance alleles as risk modifiers in familial and sporadic breast cancer

Esteban Cardeñosa E, de Juan Jiménez I, Palanca Suela S, Chirivella González I, Segura Huerta A, Santaballa Beltran A, Casals El Busto M, Barragán González E, Fuster Lluch O, Bermúdez Edo J, Bolufer Gilabert P

2012

doi: 10.1016/j.bbmt.2012.11.012

Updated Experience with Inolimomab as Treatment for Corticosteroid-Refractory Acute Graft-versus-Host Disease

García-Cadenas I, Valcárcel D, Martino R, Piñana JL, Novelli S, Esquirol A, Garrido A, Moreno ME, Granell M, Moreno C, Saavedra S, Briones J, Brunet S, Sierra J

2012

doi: 10.1016/j.ajpath.2012.07.020

Multiparameter Flow Cytometry Evaluation of Plasma Cell DNA Content and Proliferation in 595 Transplant-Eligible Patients With Myeloma Included in the Spanish GEM2000 and GEM2005 <65y Trials

Paiva B, Vídriales MB, Montalbán MÁ, Pérez JJ, Gutiérrez NC, Rosiñol L, Martínez-López J, Mateos MV, Cordón L, Oriol A, Terol MJ, Echeveste MA, De Paz R, De Arriba F, Palomera L, de la Rubia J, Díaz-Mediavilla J, Sureda A, Gorosquieta A, Alegre A, Martin A, Lahuerta JJ, Bladé J, Orfao A, San Miguel JF.

2012

doi: 10.1038/bmt.2012.25

Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning

Barba P, Martino R, Perez-Simón JA, Fernández-Avilés F, Piñana JL, Valcárcel D, Campos-Varela I, Lopez-Anglada L, Rovira M, Novelli S, Lopez-Corral L, Carreras E, Sierra J

2012

doi: 10.1016/j.fct.2012.06.012.

In vitro cytogenetic and genotoxic effects of curcumin on human peripheral blood lymphocytes

Sebastià N, Soriano JM, Barquinero JF, Villaescusa JI, Almonacid M, Cervera J, Such E, Silla MA, Montoro A

2012

doi: 10.1111/bjh.12043

Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel

Ribera JM, García O, Fernández-Abellán P, Lavilla E, Bernal MT, González-Campos J, Brunet S, Monteserín MC, Montesinos P, Sarrá J, Calbacho M, Alvarez-Larrán A, Tormo M, Oriol

2012

doi: 10.1111/j.1537-2995.2012.03704.x

Cord blood quality after vaginal and cesarean deliveries

Solves P, Perales A, Fillol M, Bonilla-Musoles F, Mirabet V

2012

doi: 10.1182/blood-2012-06-438804

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Robak T, Windyga J, Trelinski J, von Depka Prondzinski M, Giagounidis A, Doyen C, Janssens A, Alvarez-Román MT, Jarque I, Loscertales J, Rus GP, Hellmann A, Jêdrzejczak WW, Kuliczkowski K, Golubovic LM, Celeketic D, Cucuianu A, Gheorghita E, Lazaroiu M, Shpilberg O, Attias D, Karyagina E, Svetlana K, Vilchevska K, Cooper N, Talks K, Prabhu M, Sripada P, Bharadwaj TP, Næsted H, Skartved NJ, Frandsen TP, Flensburg MF, Andersen PS, Petersen J

2012

doi: 10.3324/haematol.2011.055244

Evaluation of prognostic factors among patients with chronic graft-versus-host disease

Pérez-Simón JA, Afram G, Martino R, Piñana JL, Caballero-Velazquez T, Ringden O, Valcarcel D, Caballero D, Remberger M, de Paz Y, Sierra J, Miguel JS, Hagglund H

2012

doi: 10.1016/j.gaceta.2014.12.003

Population-based multicase-control study in common tumors in Spain (MCC-Spain): Rationale and study design

Castaño-Vinyals G, Aragonés N, Pérez-Gómez B, Martín V, Llorca J, Moreno V, Altzibar JM, Ardanaz E, de Sanjosé S, Jiménez-Moleón JJ, Tardón A, Alguacil J, Peiró R, Marcos-Gragera R, Navarro C, Pollán M, Kogevinas M; MCC-Spain Study Group.

2012

doi: 10.1182/blood-2012-02-411215

Apolymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera

Hernández-Boluda JC, Pereira A, Cervantes F, Alvarez-Larrán A, Collado M, Such E, Arilla MJ, Boqué C, Xicoy B, Maffioli M, Bellosillo B, Marugán I, Amat P, Besses C, Guillem V.

2012

doi: 10.1016/j.leukres.2011.10.015

Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia

Ottone T, Cicconi L, Hasan SK, Lavorgna S, Divona M, Voso MT, Montefusco E, Melillo L, Barragán E, Platzbecker U, Giannì L, Hubmann M, Pagoni M, Amadori S, Lo-Coco F

2012

doi: 10.1016/j.medcli.2011.11.011

Diagnóstico, tratamiento y seguimiento de la trombocitopenia inmune primaria

Sanz MA, Vicente V, Fernández A, López MF, Grande C, Jarque I, Martínez R, Mingot ME, Monteagudo E, Ribera JM, Valcarcel D

2012

doi: 10.1200/JCO.2011.35.6394

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

chanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, Granada I, Hildebrandt B, Slovak ML, Ohyashiki K, Steidl C, Fonatsch C, Pfeilstöcker M, Nösslinger T, Valent P, Giagounidis A, Aul C, Lübbert M, Stauder R, Krieger O, Garcia-Manero G, Faderl S, Pierce S, Le Beau MM, Bennett JM, Greenberg P, Germing U, Haase D.

2012

doi: 10.1007/s10689-011-9481-7

Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population

de Juan Jiménez I, Esteban Cardeñosa E, Palanca Suela S, Barragán González E, Aznar Carretero I, Munárriz Gandía B, Santaballa Bertran A, Torregrosa Maicas MD, Guillén Ponce C, Sánchez Heras AB, Bayón Lara A, Fuster Lluch O, Bolufer Gilabert P

2014

doi: 10.1016/j.leukres.2011.06.011

Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia

Guillem V, Amat P, Cervantes F, Alvarez-Larrán A, Cervera J, Maffioli M, Bellosillo B, Collado M, Marugán I, Martínez-Ruiz F, Hernández-Boluda JC.

2012

doi: 10.1038/ni.2255

The Earliest Thymic T Cell Progenitors Sustain B Cell and Myeloid Lineage Potentials

Luc S, Luis TC, Boukarabila H, Macaulay IC, Buza-Vidas N, Bouriez-Jones T, Lutteropp M, Woll PS, Loughran SJ, Mead AJ, Hultquist A, Brown J, Mizukami T, Matsuoka S, Ferry H, Anderson K, Duarte S, Atkinson D, Soneji S, Domanski A, Farley A, Sanjuan-Pla A, Carella C, Patient R, de Bruijn M, Enver T, Nerlov C, Blackburn C, Godin I, Jacobsen SE

2012

doi: 10.1002/cncr.26279.

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome

Cordoba I, González-Porras JR, Nomdedeu B, Luño E, de Paz R, Such E, Tormo M, Vallespi T, Collado R, Xicoy B, Andreu R, Muñoz JA, Solé F, Cervera J, del Cañizo C; Spanish Myelodysplastic Syndrome Registry.

2012

doi: 10.1007/s00277-011-1234-z

Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia.

Fuster O, Barragán E, Bolufer P, Such E, Valencia A, Ibáñez M, Dolz S, de Juan I, Jiménez A, Gómez MT, Buño I, Martínez J, Cervera J, Montesinos P, Moscardó F, Sanz MÁ.

2012

doi: 10.1007/s00277-011-1331-z

Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia.

Gómez-Seguí I, Cervera J, Such E, Martínez-Cuadrón D, Luna I, Ibáñez M, López-Pavía M, Gascón A, Roig M, Martínez J, Sanz J, Montesinos P, Martín-Aragonés G, Lorenzo I, Senent L, Barragán E, Cordón L, Sempere A, Sanz GF, Sanz MA.

2012

2012

doi: 10.1038/emboj.2011.390

FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors

Mancini E, Sanjuan-Pla A, Luciani L, Moore S, Grover A, Zay A, Rasmussen KD, Luc S, Bilbao D, O'Carroll D, Jacobsen SE, Nerlov C

2020

doi: 10.1182/blood-2011-07-370460

High-risk Cytogenetics and Persistent Minimal Residual Disease by Multiparameter Flow Cytometry Predict Unsustained Complete Response After Autologous Stem Cell Transplantation in Multiple Myeloma

Montalbán MÁ, Martínez-López J, Mateos MV, Cibeira MT, Cordón L, Oriol A, Terol MJ, Echeveste MA, de Paz R, de Arriba F, Palomera L, de la Rubia J, Díaz-Mediavilla J, Sureda A, Gorosquieta A, Alegre A, Martin A, Hernández MT, Lahuerta JJ, Bladé J, San Miguel JF; PETHEMA/GEM (Programa para el Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español de Mieloma)

2012

Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain

Grau S, la Cámara de R, Sabater FJ, Jarque I, Carreras E, Casado MA, Sanz MA

2012

Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination

Rojas R, Molina JR, Jarque I, Montes C, Serrano J, Sanz J, Besalduch J, Carreras E, Tomas JF, Madero L, Rubio D, Conde E, Sanz MA, Torres A

2012

Bone marrow-derived cells from male donors do not contribute to the endometrial side population of the recipient

Cervelló I, Gil-Sanchis C, Mas A, Faus A, Sanz J, Moscardo F, Higueras G, Sanz MA, Pellicer A, Simón C